Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Immorna Announces First Subject Dosed in a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Vaccine Developed for the Prevention of Shingles 2023-05-30 19:00
iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome 2023-05-30 10:15
Bridge Biotherapeutics to Present at the 2023 BIO International Convention 2023-05-30 06:00
CELL WORLD - Aiming at Internationalization, Starting from Regulation - The 1st Global Cell Therapy Summit and Hillgene Biopharma Anniversary Celebration Successfully Held 2023-05-29 20:03
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer 2023-05-29 16:51
Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models 2023-05-29 13:21
ProfoundBio Announces Further Advancement of Lead Programs - PRO1184 (Rinatabart Sesutecan) and PRO1160 in the Clinic 2023-05-26 20:00
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health 2023-05-26 13:42
Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023 2023-05-25 22:00
Leading New Zealand cancer research 'super-charged' by data privacy startup 2023-05-25 21:00
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease 2023-05-25 19:00
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology 2023-05-25 19:00
TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I 2023-05-25 09:51
BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 2023-05-24 16:14
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-05-23 20:00
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study 2023-05-23 19:00
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics 2023-05-23 13:00
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin's Lymphoma 2023-05-23 00:00
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
1 51 52 53 54 55 222